|
HY-112495-25mg
|
MedChemexpress LLC
|
VH032-PEG5-C6-Cl [CAS 1799506-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-112495-5mg
|
MedChemexpress LLC
|
VH032-PEG5-C6-Cl [CAS 1799506-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-112495-50mg
|
MedChemexpress LLC
|
VH032-PEG5-C6-Cl [CAS 1799506-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-108612-10mg
|
MedChemexpress LLC
|
VU0155069 [CAS 1130067-06-9]
|
|
Cancer-programmed cell death
|
|
|
HY-108612-100mg
|
MedChemexpress LLC
|
VU0155069 [CAS 1130067-06-9]
|
|
Cancer-programmed cell death
|
|
|
HY-108612-25mg
|
MedChemexpress LLC
|
VU0155069 [CAS 1130067-06-9]
|
|
Cancer-programmed cell death
|
|
|
HY-108612-5mg
|
MedChemexpress LLC
|
VU0155069 [CAS 1130067-06-9]
|
|
Cancer-programmed cell death
|
|
|
HY-108612-50mg
|
MedChemexpress LLC
|
VU0155069 [CAS 1130067-06-9]
|
|
Cancer-programmed cell death
|
|
|
HY-108612-1mL
|
MedChemexpress LLC
|
VU0155069 [CAS 1130067-06-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-138696-10mg
|
MedChemexpress LLC
|
Zanzalintinib [CAS 2367004-54-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-138696-100mg
|
MedChemexpress LLC
|
Zanzalintinib [CAS 2367004-54-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-138696-25mg
|
MedChemexpress LLC
|
Zanzalintinib [CAS 2367004-54-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-138696-5mg
|
MedChemexpress LLC
|
Zanzalintinib [CAS 2367004-54-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-138696-50mg
|
MedChemexpress LLC
|
Zanzalintinib [CAS 2367004-54-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-138696-1mL
|
MedChemexpress LLC
|
Zanzalintinib [CAS 2367004-54-2] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
